Person placeholder

Mr. Mitchell S. Levine

Chief Financial Officer


OncoCyte Corporation logo

OncoCyte Corporation focuses on the discovery, development, and commercialization of novel and non-invasive blood and urine (liquid biopsy) diagnostic tests for the early detection of cancer. The company is developing diagnostic tests using proprietary sets of genetic and protein markers expressed in various types of cancer. It develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancer. The company was founded in 2009 and is based in Alameda, California. OncoCyte Corporation is a subsidiary of BioTime, Inc.

  • OncoCyte Corporation, 1010 Atlantic Avenue, Alameda 94501, United States
  • oncocyte.com
  • 510-775-0515
Messenger